TEL
60
2
PLD
40
2
EQIX
59
2
MTCH
57
2
ETR
65
4
HBAN
47
3
HAL
34
7
F
40
2
FDX
36
3
NAVI
40
7
STX
37
2
UAL
76
3
HSY
34
3
STT
64
5
FRT
39
3
QRVO
20
2
DD
45
4
ISRG
70
4
IP
56
6
FIS
48
5
TEL
60
2
PLD
40
2
EQIX
59
2
MTCH
57
2
ETR
65
4
HBAN
47
3
HAL
34
7
F
40
2
FDX
36
3
NAVI
40
7
STX
37
2
UAL
76
3
HSY
34
3
STT
64
5
FRT
39
3
QRVO
20
2
DD
45
4
ISRG
70
4
IP
56
6
FIS
48
5
Financhill
Back

Astria Therapeutics 10K Form

Sell
23

ATXS
Astria Therapeutics

Last Price:
$9.51
Seasonality Move:
16.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATXS News And Ratings

See the #1 stock for the next 7 days that we like better than ATXS

ATXS Financial Statistics

Sales & Book Value

Annual Sales: $500K
Cash Flow: $-28M
Price / Cash Flow: 0
Annual Sales: $4.36
Price / Book: 2.19

Profitability

EPS (TTM): -2.17000
Net Income (TTM): $-100M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Astria Therapeutics Earnings Forecast

Key Astria Therapeutics Financial Ratios

  • The Interest Expense is -0.39% of Operating Income.
  • Per Share Earnings over the last 11 years have been positive in 7 years.

Astria Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ATXS
Website: astriatx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATXS Technical Analysis vs Fundamental Analysis

Sell
23
Astria Therapeutics (ATXS) is a Sell

Is Astria Therapeutics a Buy or a Sell?